Features of folliculogenesis in women with different body mass index: a cross-sectional comparative study
- Authors: Azizova K.V.1, Volkova A.R.1, Dora S.V.1, Zimina M.V.1, Ermolinskaya T.S.1
-
Affiliations:
- Pavlov First Saint Petersburg State Medical University
- Issue: Vol 31, No 8 (2024)
- Pages: 72-77
- Section: Original articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/680232
- DOI: https://doi.org/10.18565/pharmateca.2024.8.72-77
- ID: 680232
Cite item
Abstract
Background. In recent years, there has been a tendency towards an increase in the incidence of obesity, which inevitably leads to an increase in the prevalence of a number of associated cardiovascular and metabolic diseases. The evaluation of the features of folliculogenesis in women with obesity is an important step in studying the impact of obesity on reproductive health.
Objective. Evaluation of the parameters of folliculogenesis and their relationship with metabolic parameters in women of reproductive age.
Methods. 60 women of reproductive age were examined: 16 with normal weight or overweight, 42 with obesity of varying degrees. The following parameters were assessed in all subjects: anti-Müllerian hormone, follicle-stimulating hormone, HOMA-IR insulin resistance index, number and size of antral follicles according to ultrasound examination of the pelvic organs.
Results. The number of antral follicles significantly decreased with increasing obesity, but remained within normal values. During the assessment of correlation relationships, a strong positive correlation was confirmed between the AMH level and the number of antral follicles, between the AMH level and the FSH concentration. A negative correlation was also found between BMI and the number of antral follicles with a diameter of 6–9 mm, BMI and AMH concentration, BMI and estradiol concentration.
Conclusion. The evaluation of folliculogenesis features in obese women is an important step in studying the impact of obesity on reproductive health. Further research in this area may contribute to the development of personalized approaches to the prevention and treatment of infertility and other reproductive health disorders in overweight and obese women.
Full Text

About the authors
K. V. Azizova
Pavlov First Saint Petersburg State Medical University
Author for correspondence.
Email: rika94@yandex.ru
ORCID iD: 0000-0002-2462-3320
Postgraduate Student at the Department of Faculty Therapy with the Course of Endocrinology and Cardiology with the Academician Lang Clinic
Russian Federation, Saint PetersburgA. R. Volkova
Pavlov First Saint Petersburg State Medical University
Email: rika94@yandex.ru
ORCID iD: 0000-0002-5189-9365
Russian Federation, Saint Petersburg
S. V. Dora
Pavlov First Saint Petersburg State Medical University
Email: rika94@yandex.ru
ORCID iD: 0000-0002-8249-6075
Russian Federation, Saint Petersburg
M. V. Zimina
Pavlov First Saint Petersburg State Medical University
Email: rika94@yandex.ru
Russian Federation, Saint Petersburg
T. S. Ermolinskaya
Pavlov First Saint Petersburg State Medical University
Email: rika94@yandex.ru
ORCID iD: 0009-0009-4464-5912
Russian Federation, Saint Petersburg
References
- Всемирная организация здравоохранения. Ожирение и избыточная масса тела. 2024. [Электронный ресурс]. [World Health Organization. Obesity and overweight. 2024. [Electronic resource]. (In Russ.)]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
- Андреева Е.Н., Шереметьева Е.В., Фурсенко В.А. Ожирение – угроза репродуктивного потенциала России. Ожирение и метаболизм. 2019;16:20–28. [Andreeva E.N., Sheremetyeva E.V., Fursenko V.A. Obesity is a threat to Russia’s reproductive potential. Obesity and Metabolism. 2019;16:20–28. (In Russ.)]. doi: 10.14341/omet10340.
- Есжанова А., Халмуратова К., Сагандыкова Г. и др. Ожирение и фертильность: обзор литературы. Репродуктивная медицина. 2023;55:39–45. [Eszhanova A., Khalmuratova K., Sagandykova G., et al. Obesity and fertility: a literature review. Reproductive Medicine. 2023;55:39–45. (In Russ.)]. doi: 10.37800/RM.2.2023.39-45.
- Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021 Sep 6;12:706978. doi: 10.3389/fendo.2021.706978.
- Бекбаева И.В., Муковникова Е.В., Кыртиков С.И. и др. Репродуктивный потенциал женщин с ожирением. Акушерство и гинекология: Новости. Мнения. Обучения. 2023;11(Спецвыпуск):126–131. [Bekbaeva I.V., Mukovnikova E.V., Kyrtikov S.I., et al. Reproductive potential of women with obesity. Obstetrics and Gynecology: News. Opinions. Training. 2023;11(Special Issue):126–131. (In Russ.)]. doi: 10.33029/2303-9698-2023-11-suppl-126-131.
- Oldfield A.L., Vanden Brink H., Carter F.E., et al. Obesity is associated with alterations in antral follicle dynamics in eumenorrheic women. Human Reproduction. 2023;38(3):459–470. doi: 10.1093/humrep/dead007.
- Kloos J., Coyne K., Weinerman R. The relationship between anti-Müllerian hormone, body mass index and weight loss: A review of the literature. Clin Obes. 2022;12(6):e12559. doi: 10.1111/cob.12559.
- Greenwood Jaswa E., Rios J.S., Cedars M.I., et al. Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone. J Clin Endocrinol Metab. 2020;105(10):3234–3242. doi: 10.1210/clinem/dgaa436.
- Czech I., Partyka M., Drosdzol-Cop A. Does body mass index affect anti-mullerian hormone levels in girls and adolescents? Ginekol Pol. 2023. doi: 10.5603/GP.a2023.0013.
- Lainez N.M., Coss D. Obesity, Neuroinflammation, and Reproductive Function. Endocrinology. 2019;160(11):2719–2736. doi: 10.1210/en.2019-00487.
- Андреева Е.Н., Абсатарова Ю.С., Шереметьева Е.В., Фурсенко В.А. Ожирение и репродуктивная функция у женщин: эпигенетические и сомато-психологические особенности. Ожирение и метаболизм. 2019;16:9–15. [Andreeva E.N., Absatarova Yu.S., Sheremetyeva E.V., Fursenko V.A. Obesity and reproductive function of women: epigenetic and somato-psychological features. Obesity and metabolism. 2019;16(2):9–15. (In Russ.)].doi: 10.14341/omet10113.
- Дедов И.И., Шестакова М.В., Мельниченко Г.А. и др. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний». Ожирение и метаболизм. 2021;18:5–99. [Dedov I.I., Shestakova M.V., Melnichenko G.A., et al. Interdisciplinary clinical guidelines «Treatment of obesity and comorbid diseases». Obesity and Metabolism. 2021;18:5–99. (In Russ.)]. doi: 10.14341/omet12714.
- Coelho Neto M.A., Ludwin A., Borrell A., et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2018;51(1):10–20. doi: 10.1002/uog.18945.
- Дедов И.И., Шестакова М.В., Майоров А.Ю. и соав. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й выпуск. Сахарный диабет. 2023;26(2S):1–157. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. Issue 11. Diabetes mellitus. 2023;26(2S):1–157. (In Russ.)]. doi: 10.14341/DM13042.
- Lin L., Chen G., Liu Y. Value of estrogen pretreatment in patients with diminished ovarian reserve and elevated FSH on a line antagonist regimen: a retrospective controlled study. Ovarian Res. 2024;17(1):114. doi: 10.1186/s13048-024-01415-2.
- Testing and interpreting measures of ovarian reserve: a committee opinion. American Society for Reproductive Medicine; 2020. URL: https://www.asrm.org/practice-guidance/practice-committee-documents/testing-and-interpreting-measures-of-ovarian-reserve-a-committee-opinion-2020 (date of access: 25.10.2024).
- Marinelli S., Napoletano G., Straccamore M., Basile G. Female obesity and infertility: outcomes and regulatory guidance. Acta Biomed. 2022;93(4):e2022278. doi: 10.23750/abm.v93i4.13466.
- Armstrong A., Berger M., Al-Safi Z. Obesity and reproduction. Curr Opin Obstet Gynecol. 2022;34:184–189. doi: 10.1097/GCO.0000000000000794.
- Fichman V., Costa R.S.S.D., Miglioli T.C., Marinheiro L.P.F. Association of obesity and anovulatory infertility. Einstein (Sao Paulo). 2020;18:1–5. doi: 10.31744/einstein_journal/2020AO5150.
- Bloom M.S., Perkins N.J., Sjaarda L.A., et al. Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study. Paediatr Perinat Epidemiol. 2021;35(2):174–183. doi: 10.1111/ppe.12726.
- Hamilton J.A.M., van der Steeg J.W., Hamilton C.J.C.M., de Bruin J.P. A concise infertility work-up results in fewer pregnancies. Human Reproducion Open. 2021;4:1–11. doi: 10.1093/hropen/hoab033.
- Karolien L.J. Desmet, Waleed F.A. Marei, Richard C., et al. Oocyte maturation under lipotoxic conditions induces carryover transcriptomic and functional alterations during post-hatching development of good-quality blastocysts: novel insights from a bovine embryo-transfer model. Human Reproduction. 2020;35(2):293–307. doi: 10.1093/humrep/dez248.
- Waleed F.A. Marei, Smits A., Mohey-Elsaeed O., et al. Differential effects of high fat diet-induced obesity on oocyte mitochondrial functions in inbred and outbred mice. Sci Rep. 2020;10(1):9806. doi: 10.1038/s41598-020-66702-6.
- Yun Y., Wei Z., Hunter N. Maternal obesity enhances oocyte chromosome abnormalities associated with aging. Chromosoma. 2019;128:413–421. doi: 10.1007/s00412-019-00716-6.
- Покровская Е.В., Шестакова Е.А., Шестакова М.В. Эндотелиальная дисфункция у лиц с ожирением при наличии и отсутствии сахарного диабета 2 типа: оценка специфических маркеров. Сахарный диабет. 2023;26:439–445. [Pokrovskaya E.V., Shestakova E.A., Shestakova M.V. Endothelial dysfunction in obese individuals with and without type 2 diabetes mellitus: assessment of specific markers. Diabetes Mellitus. 2023;26:439–445. (In Russ.)]. doi: 10.14341/DM13088.
- Чусова Н.А. Роль эндотелиальной дисфункции при ожирении. Международный студенческий научный вестник. 2019;5(часть 2). [Chusova N.A. The role of endothelial dysfunction in obesity. International Student Scientific Bulletin. 2019;5(Part 2). (In Russ.)].
- Hong K.J., Lin J.J., Lin LH., et al. The intrafollicular concentration of leptin as a potential biomarker to predict oocyte maturity in in-vitro fertilization. Sci Rep. 2022;12 (1):19573. doi: 10.1038/s41598-022-23737-1.
Supplementary files
